| Abstract | Mycobacterium bovis bacille Calmette Guérin (BCG) is one of the most widely used live vaccines. Technologic advancement in genome manipulation enables the construction of recombinant BCG (rBCG) strains, which can be employed as highly immunogenic vaccines against tuberculosis with improved safety profile. |
| Authors | Ali Nasser Eddine, Stefan H E Kaufmann
(Affiliation: Department of Immunology, Max-Planck Institute for Infection Biology, Schumannstr. 21/22, 10117 Berlin, Germany.)
|
| Journal | Microbes and infection / Institut Pasteur
(Microbes Infect)
Vol. 7
Issue 5-6
Pg. 939-46
(May 2005)
ISSN: 1286-4579 France |
| PMID | 15890553
(Publication Type: Journal Article)
|
| Chemical References |
- BCG Vaccine
- Vaccines, Synthetic
|
| Topics |
- BCG Vaccine
(administration & dosage, adverse effects)
- Humans
- Tuberculosis
(prevention & control)
- Vaccines, Synthetic
(administration & dosage, adverse effects)
|
